1. Home
  2. MCHX vs PYXS Comparison

MCHX vs PYXS Comparison

Compare MCHX & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCHX
  • PYXS
  • Stock Information
  • Founded
  • MCHX 2003
  • PYXS 2018
  • Country
  • MCHX United States
  • PYXS United States
  • Employees
  • MCHX N/A
  • PYXS N/A
  • Industry
  • MCHX Business Services
  • PYXS Biotechnology: Pharmaceutical Preparations
  • Sector
  • MCHX Consumer Discretionary
  • PYXS Health Care
  • Exchange
  • MCHX Nasdaq
  • PYXS Nasdaq
  • Market Cap
  • MCHX 84.3M
  • PYXS 79.4M
  • IPO Year
  • MCHX 2004
  • PYXS 2021
  • Fundamental
  • Price
  • MCHX $1.83
  • PYXS $3.48
  • Analyst Decision
  • MCHX
  • PYXS Strong Buy
  • Analyst Count
  • MCHX 0
  • PYXS 5
  • Target Price
  • MCHX N/A
  • PYXS $7.75
  • AVG Volume (30 Days)
  • MCHX 37.8K
  • PYXS 877.2K
  • Earning Date
  • MCHX 11-14-2025
  • PYXS 11-11-2025
  • Dividend Yield
  • MCHX N/A
  • PYXS N/A
  • EPS Growth
  • MCHX N/A
  • PYXS N/A
  • EPS
  • MCHX N/A
  • PYXS N/A
  • Revenue
  • MCHX $47,534,000.00
  • PYXS $2,820,000.00
  • Revenue This Year
  • MCHX N/A
  • PYXS N/A
  • Revenue Next Year
  • MCHX $7.56
  • PYXS N/A
  • P/E Ratio
  • MCHX N/A
  • PYXS N/A
  • Revenue Growth
  • MCHX N/A
  • PYXS N/A
  • 52 Week Low
  • MCHX $1.26
  • PYXS $0.83
  • 52 Week High
  • MCHX $2.40
  • PYXS $5.39
  • Technical
  • Relative Strength Index (RSI)
  • MCHX 46.50
  • PYXS 60.49
  • Support Level
  • MCHX $1.73
  • PYXS $3.17
  • Resistance Level
  • MCHX $1.89
  • PYXS $3.75
  • Average True Range (ATR)
  • MCHX 0.09
  • PYXS 0.31
  • MACD
  • MCHX -0.00
  • PYXS -0.05
  • Stochastic Oscillator
  • MCHX 32.31
  • PYXS 33.62

About MCHX Marchex Inc. Class B

Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.

About PYXS Pyxis Oncology Inc.

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

Share on Social Networks: